A Phase I Study of Metronomic Temozolomide and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma

Trial Profile

A Phase I Study of Metronomic Temozolomide and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma

Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Ascorbic acid (Primary) ; Temozolomide (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Dec 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
    • 04 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top